EXICURE, INC. Increase (Decrease) in Due from Related Parties, Current
EXICURE, INC. (XCUR) reported Increase (Decrease) in Due from Related Parties, Current of $6.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent · last filed 2019-11-07
- EXICURE, INC. increase (decrease) in due from related parties, current for the quarter ending 2019-09-30 was $5.00K.
- EXICURE, INC. increase (decrease) in due from related parties, current for the quarter ending 2019-06-30 was $8.00K, a 66.67% decline year-over-year.
- EXICURE, INC. increase (decrease) in due from related parties, current for the quarter ending 2019-03-31 was -$7.00K, a 275.00% decline year-over-year.
- EXICURE, INC. increase (decrease) in due from related parties, current for the quarter ending 2018-12-31 was $6.00K, a 50.00% increase year-over-year.
- EXICURE, INC. increase (decrease) in due from related parties, current for fiscal 2018 was -$7.00K, a 450.00% decline from fiscal 2017.
- EXICURE, INC. increase (decrease) in due from related parties, current for fiscal 2017 was $2.00K.
- EXICURE, INC. increase (decrease) in due from related parties, current for fiscal 2016 was -$42.00K.
| Period end | Increase (Decrease) in Due from Related Parties, Current 3 month | Increase (Decrease) in Due from Related Parties, Current 6 month | Increase (Decrease) in Due from Related Parties, Current 9 month | Increase (Decrease) in Due from Related Parties, Current 12 month |
|---|---|---|---|---|
| 2019-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $13.00K derived: sum of 2 quarters · filed 2019-11-07 | $6.00K 10-Q · filed 2019-11-07 | $12.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.00K 10-Q · filed 2019-08-08 | $7.00K derived: sum of 3 quarters · filed 2019-09-23 | -$34.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | -$7.00K 10-Q · filed 2019-05-08 | -$1.00K derived: sum of 2 quarters · filed 2019-09-23 | -$42.00K derived: sum of 3 quarters · filed 2019-11-07 | -$18.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | $6.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | -$35.00K derived: sum of 2 quarters · filed 2019-11-07 | -$11.00K derived: sum of 3 quarters · filed 2019-11-07 | -$7.00K 10-K/A · filed 2019-09-23 |
| 2018-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$17.00K derived: sum of 2 quarters · filed 2019-11-07 | -$13.00K 10-Q · filed 2019-11-07 | -$9.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $28.00K 10-Q · filed 2019-08-08 | $32.00K derived: sum of 3 quarters · filed 2019-09-23 | $36.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2018-03-31 | $4.00K 10-Q · filed 2019-05-08 | $8.00K derived: sum of 2 quarters · filed 2019-09-23 | $12.00K derived: sum of 3 quarters · filed 2019-09-23 | $1.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2017-12-31 | $4.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | $8.00K derived: sum of 2 quarters · filed 2019-09-23 | -$3.00K derived: sum of 3 quarters · filed 2019-09-23 | $2.00K 10-K/A · filed 2019-09-23 |
| 2017-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$7.00K derived: sum of 2 quarters · filed 2018-11-06 | -$2.00K 10-Q · filed 2018-11-06 | $5.00K derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$6.00K 10-Q · filed 2018-08-06 | $1.00K derived: sum of 3 quarters · filed 2018-08-06 | |
| 2017-03-31 | $5.00K 10-Q · filed 2018-05-15 | $12.00K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$42.00K 10-K · filed 2018-03-09 | ||
| 2016-09-30 | -$49.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |